TNNC1 | Troponin C type 1 (slow) | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
POU2F3 | POU class 2 homeobox 3 | Transcription factors
| | | | | Tissue enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FDX1 | Ferredoxin 1 | Mitochondrial proteins
| | | | | Tissue enriched |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
TRIM29 | Tripartite motif containing 29 | | | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Group enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
NFE2 | Nuclear factor, erythroid 2 | Transcription factors
| | | | | Tissue enriched |
PLCD4 | Phospholipase C, delta 4 | Enzymes
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
DSC3 | Desmocollin 3 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
GKAP1 | G kinase anchoring protein 1 | | | | | | Tissue enriched |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
MYH6 | Myosin, heavy chain 6, cardiac muscle, alpha | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
RSPH4A | Radial spoke head 4 homolog A (Chlamydomonas) | Cytoskeleton related proteins Disease related genes
| | | | | Tissue enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | | Group enriched |
TYRP1 | Tyrosinase-related protein 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase | Enzymes Plasma proteins
| | | | | Tissue enriched |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Group enriched |
DDX20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 | Cytoskeleton related proteins Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
NECAB1 | N-terminal EF-hand calcium binding protein 1 | | | | | | Tissue enriched |
NUP155 | Nucleoporin 155kDa | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PGC | Progastricsin (pepsinogen C) | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | | | Group enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
TTC21A | Tetratricopeptide repeat domain 21A | | | | | | Group enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | | Tissue enriched |
CCDC19 | Coiled-coil domain containing 19 | | | | | | Group enriched |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
H1FX | H1 histone family, member X | Plasma proteins
| | | | | Tissue enriched |
HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
KDM5B | Lysine (K)-specific demethylase 5B | Transcription factors
| | | | | Tissue enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
LRRC23 | Leucine rich repeat containing 23 | | | | | | Group enriched |